What's New

This app has been updated by Apple to use the latest Apple signing certificate.

1. Removed bluetooth option for Glucometer reading transfer
2. Added logic into the app where if a Glucose reading of less than 70mg/dl (Hypoglycemic Event), it automatically redirects you to symptom reporting screens.

App Description

"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.

The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."

iPhone Screenshots

(click to enlarge)

POINT 1 Study screenshot 1 POINT 1 Study screenshot 2 POINT 1 Study screenshot 3 POINT 1 Study screenshot 4 POINT 1 Study screenshot 5

iPad Screenshots

(click to enlarge)

POINT 1 Study screenshot 6 POINT 1 Study screenshot 7

App Changes

  • June 16, 2019 Initial release

Other Apps From Parallel 6, Inc.

ABASD Room Finds stay local. Payson Petroleum OfferHubb App Top Tech Awards 6 Appeal Miramar Touch The Pivot Study TAReSA's Care Circle TAReSA Clinical6 Mobile Sanofi ACT14132 Site App Sanofi ACT14132 Patient App My APPLES Study Paratek PTK0796-UUTI-17201 Strata Oncology eStudy Subject App mClinical CCA GepoER Meds POINT 1 Study Site e-Study Lite Otsuka 31-14-204 Telemedicine GepoER e-Study Traditional VIR Patient Mobile App RELIEF Study Participant Vedanta-VE800 CHIEF-HF Virtual Study Support Valneva Release MSS1 Release MSS3 KRYSTAL-7 Vaccitech Release SCIS1 MHP-OA Study Release MSS5 VLA1553-302 NATiV3 KRYSTAL-12 Release MSS2 Herald Study Triumph Study Vertex MAGNIFY